Dmitry Balyasny’s Yarrow Bioscience YARW Stock Holding History

Dmitry Balyasny’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3	Closed	-$96K	–	2070
2018 Q2	$96K	Buy	+3	New	+$117K	﹤0.01%	1710

Other funds holding YARW

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dmitry Balyasny's YARW Position: Q3 2018 in Review

Dmitry Balyasny sold out of Yarrow Bioscience (YARW) in Q3 2018, closing a stake of 3 shares — an estimated $96K sold.

Dmitry Balyasny first reported a position in YARW in Q2 2018 and held it in 1 quarter. The position peaked at $96K in Q2 2018. 42 funds tracked by Wall St. Rank hold YARW as of Q3 2018.

Dmitry Balyasny reported no remaining Yarrow Bioscience position as of Q3 2018 after selling out during the quarter.
Dmitry Balyasny sold 3 Yarrow Bioscience shares in Q3 2018, an estimated $96K.
Dmitry Balyasny first reported a position in Yarrow Bioscience in Q2 2018 and held it in 1 quarter.
Dmitry Balyasny's Yarrow Bioscience position peaked at $96K in Q2 2018.
42 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2018.

Based on Balyasny Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.